VMD Stock — Viemed Healthcare Inc

Viemed Healthcare Inc (VMD)

Updated October 16, 2026.

VMD is a Stock. Total return is 428.5% over the past 8.8 years, 207.6 points ahead of SPY at 220.9%.

Viemed Healthcare provides home medical equipment and post-acute respiratory healthcare services in the United States, including treatment for chronic obstructive pulmonary disease, sleep apnea management, oxygen therapy, and related medical equipment rental and support services. The company does not currently maintain an established distribution schedule. This business may appeal to healthcare-focused investors seeking exposure to the home medical equipment and respiratory care sectors.

VMD performance versus SPY

Price and return data through 2026-10-16.

Total return is 428.5% over the past 8.8 years, 207.6 points ahead of SPY at 220.9%. Over the past year its total return — price change plus distributions reinvested — is 38.4%. Its deepest 1-year drawdown was 30.5%.

VMD key facts

Asset type

Stock

Asset class

Equity

Inception date

01/04/2018

Distribution frequency

None

Last close

$9.48 (as of 2026-10-16)

Market cap

$361,076,401

Average volume

329430.0

Beta

1.042

Payout ratio

0.0%

P/E ratio

26.33

Forward P/E

18.3486

EPS

$0.36

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

VMD risks and drawbacks

The deepest 1-year drawdown on record here is 30.5%.

Who may consider VMD — and who may not

It is a weaker fit for investors who need monthly cash flow (VMD does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on VMD

• All tickers starting with V

Tagged: Healthcare.

Frequently asked questions